Viemed Healthcare, Inc. / Fundamental strength relative to industry (Mohanram G-Value)

    The G-Value, developed by Mohanram in 2005, is a measure of a fundamental strength for growth companies. According to Mohanram, a low G-Value suggests a higher probability that a stock may be overvalued relative to its growth potential due to hype or overexcitement. The approach is described in detail in Mohanram's 2005 Paper Separating Winners from Losers among LowBook-to-Market Stocks using Financial Statement Analysis.

    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7
    Return on assets (ROA) greater than industry median
    check 6.2% > 5.1%
    Operating cash flow over total assets greater than industry median
    check 26.5% > 11.5%
    Operating cash flow greater than net income
    check $33.79M > $7.85M
    Variance in ROA over the last 5 years less than industry median
    close 0.5% ≥ 0.1%
    Variance in year-over-year sales growth over the last 5 years less than industry median
    close 3.1% ≥ 2.8%
    R&D expenses over total assets greater than industry median
    check 1.9% > 0.0%
    Capex over total assets greater than industry median
    check 15.9% > 2.3%

    G-Value history

    The G-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the G-Value at a specific time in the past.

    5
    5
    6
    7
    5
    6
    5
    6
    5
    5
    4
    4
    4
    4
    4
    5
    5
    5
    5
    5

    Notifications